Breast Cancer Antigen CA 15-3
Cancer antigen CA 15-3 is a normal product of breast cells. It is a highly polymorphic glycoprotein belonging to the mucin family and is the product of the MUC-1 gene. Overexpression of CA 15-3 is associated with metastatic breast cancer and this test is used to monitor breast cancer and to follow the course of treatment. Elevated serum CA 15-3 concentrations have been reported in 5% of stage I, 29% of stage II, 32% of stage III, and 95% of stage IV carcinoma of the breast. When used in conjunction with other clinical and diagnostic procedures, serial testing for CA 15-3 cancer antigen is useful for monitoring the course of disease and therapy in metastatic breast cancer patients, and for detection of recurrence in previously treated Stage II or Stage III breast cancer patients. In patients with known metastases, a reduction in CA 15-3 levels indicates a good response to treatment, while increasing levels indicate resistance to therapy and progressive disease. CA 15-3 is not sensitive or specific enough to be considered useful as a tool for cancer screening, but has been used as an approximation of the severity of the disease. Mild to moderate elevation of CA 15-3 is also seen in other conditions including liver and pancreatic cancer, cirrhosis, benign breast disorders, and infrequently in apparently healthy individuals, especially women who are pregnant or nursing. CA 15-3 elevations seen in non-cancerous conditions tend to be stable over time.
- Monitoring the course of disease and therapy in metastatic breast cancer patients
- Management of stage II and stage III breast cancer patients
- May aid in initial diagnosis of cancer of unknown origin.
Elevated in:
- Metastatic breast cancer
- Also may be elevated (low levels) in pancreatic cancer, colon cancer, liver cancer, endometrium cancer, cervix cancer, lung cancer, and ovarian cancer
- Cirrhosis
- Benign breast disorders
- Very low levels might be present in apparently healthy individuals
The test is not specific for breast cancer. Elevated values have been reported in primary cancer of the lung, liver, pancreas, ovary, endometrium, cervix and colon. Some benign liver and breast diseases may show elevated values as well.
0 - 32.4 U/mL
Serum (SST), Plasma EDTA (Lavender), Heparin (Green) or ACD (Yellow).
Stability
- Ambient: 3-5 days
- Refrigerated: 7 days
- Frozen: 60 days
- Oncology. 2012;82(3):180-7. [PMID: 22433564]
- Eur J Obstet Gynecol Reprod Biol. 1999 Mar;83(1):67-75. [PMID: 10221613]
- Tumour Biol. 2002 Nov-Dec;23(6):315-23. [PMID: 12677089]
- Ann Clin Biochem. 1999 Sep;36 ( Pt 5):579-86. [PMID: 10505206]
- Br J Cancer. 1997;75(5):698-702. [PMID: 9043027]
- Eur J Cancer. 1992;29A(1):144-6. [PMID: 1445733]
- Cancer. 1991 Aug 1;68(3):574-82. [PMID: 2065278]